Adam S. Mostafa
Net Worth
Last updated:
What is Adam S. Mostafa net worth?
The estimated net worth of Mr. Adam S. Mostafa is at least $2,758,109 as of 7 Oct 2024. He owns shares worth $156,455 as insider, has earned $598,854 from insider trading and has received compensation worth at least $2,002,800 in X4 Pharmaceuticals, Inc..
What is the salary of Adam S. Mostafa?
Mr. Adam S. Mostafa salary is $400,560 per year as Chief Financial Officer, Treasurer & Assistant Sec. in X4 Pharmaceuticals, Inc..
How old is Adam S. Mostafa?
Mr. Adam S. Mostafa is 45 years old, born in 1980.
What stocks does Adam S. Mostafa currently own?
As insider, Mr. Adam S. Mostafa owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. (XFOR) | Chief Financial Officer, Treasurer & Assistant Sec. | 52,500 | $2.98 | $156,455 |
What does X4 Pharmaceuticals, Inc. do?
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co., Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company was founded in 2010 and is headquartered in Boston, Massachusetts.
Adam S. Mostafa insider trading
X4 Pharmaceuticals, Inc.
Mr. Adam S. Mostafa has made 20 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 230,645 units of XFOR stock worth $126,855 on 7 Oct 2024.
The largest trade he's ever made was exercising 230,645 units of XFOR stock on 1 Nov 2023. As of 7 Oct 2024 he still owns at least 52,500 units of XFOR stock.
X4 Pharmaceuticals key executives
X4 Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Paula Ragan Ph.D. (55) Founder, Chief Executive Officer, Pres, Sec. & Director
- Mr. Adam S. Mostafa (45) Chief Financial Officer, Treasurer & Assistant Sec.
- Mr. Derek M. Meisner Esq., J.D. (54) Chief Legal Officer & Corporation Sec.